This inventor holds 1 USPTO granted patent. Top assignee: Cancer Research Technology Limited. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Martin Philpott: Innovator in Cancer Treatment
Introduction
Martin Philpott is a notable inventor based in Auckland, New Zealand. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic methods.
Latest Patents
Philpott holds a patent for a groundbreaking cancer treatment by combination therapy. This patent outlines methods and compositions for treating cancer, which include administering a compound from the xanthenone acetic acid group alongside compounds that modulate TNF production or act on biochemical pathways leading to TNF synthesis. The compositions also incorporate acceptable pharmaceutical carriers and vehicles.
Career Highlights
Philpott is associated with Cancer Research Technology Limited, where he applies his expertise to advance cancer treatment methodologies. His work is pivotal in the ongoing fight against cancer, showcasing his commitment to improving patient outcomes.
Collaborations
Throughout his career, Philpott has collaborated with esteemed colleagues such as Bruce Charles Baguley and Lai-Ming Ching. These partnerships have further enriched his research and contributed to the development of effective cancer therapies.
Conclusion
Martin Philpott's innovative work in cancer treatment exemplifies the impact of dedicated research and collaboration in the medical field. His contributions continue to inspire advancements in therapeutic approaches to combat cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile